Zoledronic acid ameliorates the effects of endocrine therapy on bone health in women with early-stage breast cancer.
Coleman
Robert E
RE
Academic Unit of ClinicalOncology, Weston Park Hospital, Sheffield, UK. r.e.coleman@sheffield.ac.uk